Roger Seheult, MD of MedCram examines monoclonal antibodies and how they interact with the omicron variant. See all Dr. Seheult’s videos at: https://www.medcram.com
Clinical trial data for Paxlovid show that if taken within 3 days of symptom onset, hospitalizations and death were reduced by 89% compared to placebo.
(This video was recorded on January 4, 2022)
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
LINKS / REFERENCES:
FACT SHEET FOR HEALTHCARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF SOTROVIMAB (Infusion Center) | http://infusioncenter.org/wp-content/…
Anti-SARS-CoV-2 Monoclonal Antibodies: Selected Clinical Data (NIH) | https://www.covid19treatmentguideline…
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 (bioRxiv) | https://www.biorxiv.org/content/10.11…
If You Get COVID 19: Optimize Immune System (MedCram) | https://youtu.be/vN30emwcNS4
Merck COVID Pill (Molnupiravir): A New Treatment Option? (MedCram) | https://youtu.be/aI0xGfITaas
Pfizer COVID 19 FDA Authorized Pill “Paxlovid” Explained (MedCram) | https://youtu.be/GMMTw0MAT-8
All coronavirus updates are at MedCram.com (including more discussion on new COVID variants, fluvoxamine, Pfizer covid pill, and more).
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:
Get notified of new videos by hitting the bell icon.